Natasha Giordano

Natasha Giordano is currently Chairman at Incora Health, Inc. since 2025, Independent Director at Oragenics, Inc. since 2025, and Director at Afaxys, Inc. since 2024.
Former positions include President, Chief Executive Officer & Director at PLx Pharma, Inc. from 2016 to 2023; Independent Director at Matinas BioPharma Holdings, Inc. from 2020 to 2025; President, Chief Executive Officer & Director at Xanodyne Pharmaceuticals, Inc. from 2011 to 2012; Chief Executive Officer & Director at ClearPoint, Inc. in 2015; President & Chief Executive Officer at Clearpoint Learning, Inc. in 2015; Independent Director at Actylis Corp.
from 2011 to 2019; President & Director at Healthcare Corp.
of America in 2014; Director-Strategic Alliances & Sales Integration at Pfizer Pharmaceuticals, Inc. from 1999 to 2000; President-Americas at Dendrite International, Inc. from 2007 to 2008; Director-Northeast Customer Business Unit at Warner-Lambert Co.; and Director-Strategic Alliances & Sales Integration at Parke, Davis & Co. LLC.
Education includes undergraduate studies at Wagner College (New York).